Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02325414 · ClinicalTrials.gov registry record · Phase 2

Prevention of Bone Loss After Acute SCI by Zoledronic Acid

A Phase 2 study of Spinal Cord Injury and Osteoporosis, sponsored by Northwestern University.

Completed
Registry status
Phase 2
Development phase
60
Enrollment target
2
Study locations

NCT02325414 is a Phase 2 study of Spinal Cord Injury and Osteoporosis that has completed, run by Northwestern University. The registered enrollment target is 60 participants, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (30% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02325414, a Phase 2 study of Spinal Cord Injury and Osteoporosis, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
Phase 2
Development phase
60 participants
Enrollment target
2
Study locations

Study Summary

The overall objective of this study is to define an effective therapeutic approach, using currently available medication, to prevent or mitigate the loss of bone mass and bone strength that occurs after acute spinal cord injury.

Conditions Studied

Spinal Cord Injury Osteoporosis Bone Loss Acute Spinal Cord Injury

Interventions

  • DRUG Placebo
  • DRUG Zoledronic acid

Study Locations (2)

Illinois

  • Northwestern University Feinberg School of Medicine - Chicago
  • Rehabilitation Institute of Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2015-02
Est. Completion 2020-08-25
Phase Phase 2

Sponsor

Northwestern University

1,209 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02325414

The ClinicalTrials.gov registry entry for NCT02325414 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (30% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Spinal Cord Injury appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT02325414 reports 2 study locations spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT02325414 about?

NCT02325414 is a clinical study titled "Prevention of Bone Loss After Acute SCI by Zoledronic Acid". The overall objective of this study is to define an effective therapeutic approach, using currently available medication, to prevent or mitigate the loss of bone mass and bone strength that occurs after acute spinal cord injury.

What is the current status of trial NCT02325414?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2015-02. Estimated completion is 2020-08-25.

What conditions does trial NCT02325414 study?

This clinical trial studies the following conditions: Spinal Cord Injury, Osteoporosis, Bone Loss, Acute Spinal Cord Injury.

What interventions are being tested in trial NCT02325414?

The interventions under investigation include: Placebo (DRUG), Zoledronic acid (DRUG).

Who is sponsoring clinical trial NCT02325414?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02325414 being conducted?

This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Spinal Cord Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Spinal Cord Injury

All registered trials for this condition

Osteoporosis

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.